Mark Warnock
Impact in
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms
Papers in
- Hematology 13
- Blood Coagulation and Thrombosis Mechanisms 13
- Platelet Disorders and Treatments 3
- Genetics 12
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 11
- Co-authors
- Daniel A. Lawrence (17 shared papers)Alvin H. Schmaier (9 shared papers)Ginette R. Webb (3 shared papers)Christopher J. Elson (1 shared paper)Fakhri Mahdi (5 shared papers)John W. Regan (1 shared paper)Cynthia J. DeLong (1 shared paper)Stephen J. Wilson (1 shared paper)
- Journals
- Blood (4 papers)Journal of Biological Chemistry (4 papers)Journal of Neuroinflammation (2 papers)JCI Insight (2 papers)Scientific Reports (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Mark Warnock
31 papers receiving 1.3k citations
Mark Warnock's Hit Papers
Peers
Comparison fields: 5 of 105
- Biochemistry 156
- Hematology 205
- Genetics 151
- Nutrition and Dietetics 216
- Cancer Research 194
Countries citing papers authored by Mark Warnock
This map shows the geographic impact of Mark Warnock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Warnock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Warnock more than expected).
Fields of papers citing papers by Mark Warnock
This network shows the impact of papers produced by Mark Warnock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Warnock. The network helps show where Mark Warnock may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Warnock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 321 | |
| 2 | 1997 | 166 | |
| 3 | Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients Hit paper breakdown → | 2021 | 150 |
| 4 | 2008 | 112 | |
| 5 | 2007 | 84 | |
| 6 | 2006 | 69 | |
| 7 | 2013 | 66 | |
| 8 | 2011 | 46 | |
| 9 | 2015 | 39 | |
| 10 | 2010 | 35 | |
| 11 | 2018 | 35 | |
| 12 | 2003 | 33 | |
| 13 | 1997 | 33 | |
| 14 | 2004 | 31 | |
| 15 | 1997 | 18 | |
| 16 | 2022 | 17 | |
| 17 | 2004 | 14 | |
| 18 | 2013 | 14 | |
| 19 | 2018 | 13 | |
| 20 | 2008 | 11 |
About Mark Warnock
Mark Warnock is a scholar working on Hematology, Genetics, Cancer Research, Neurology and Cardiology and Cardiovascular Medicine, having authored 33 papers that have together received 1.4k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (13 papers), Protease and Inhibitor Mechanisms (12 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers), Inflammatory mediators and NSAID effects (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Platelet Disorders and Treatments (3 papers) and Nerve injury and regeneration (2 papers). The work is most often cited by research in Biochemistry (156 citations), Hematology (205 citations), Genetics (151 citations), Nutrition and Dietetics (216 citations) and Cancer Research (194 citations). Mark Warnock has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Daniel A. Lawrence, Alvin H. Schmaier, Ginette R. Webb, Christopher J. Elson, Fakhri Mahdi, John W. Regan, Cynthia J. DeLong, Stephen J. Wilson, Yu Hong and Chong Yuan. Their work appears in journals such as Blood, Journal of Biological Chemistry, Journal of Neuroinflammation, JCI Insight and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.